Cargando…
Anti-rods and rings autoantibodies can occur in the hepatitis c-naïve population
INTRODUCTION. The anti-Rods and Rings autoantibody recently described in clinical populations is thought to occur in the setting of hepatitis C treatment, specifically in the context of cytidine triphosphate (CTP) and guanosine triphosphate (GTP) synthetic pathway inhibitors, and is important in its...
Autores principales: | SHAIKH, Y., KRANTZ, A., EL-FARRA, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718377/ https://www.ncbi.nlm.nih.gov/pubmed/24783898 |
Ejemplares similares
-
Anti-Rods and Rings Autoantibodies in a Patient With Hepatitis C Virus Infection
por: Choi, Kyung Ho, et al.
Publicado: (2015) -
Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence
por: Assandri, Roberto, et al.
Publicado: (2021) -
Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection
por: Calise, S. John, et al.
Publicado: (2016) -
The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection
por: Afsharzadeh, Fatemeh, et al.
Publicado: (2016) -
Anti-Rods/Rings: A Human Model of Drug-Induced Autoantibody Generation
por: Calise, S. John, et al.
Publicado: (2015)